The Valneva anti-covid vaccine, the first with an inactivated virus, could receive the European green light for the Valneva anti-Covid vaccine by the end of March. The French company announces today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency EMA has provided an initial evaluation on VLA2001 – this is the name of the new product-shield candidate against Sars-CoV-2 – by submitting to Valneva a list of questions that the company expects to be able to answer in the next few days. If all goes as expected, then, Valneva expects to receive “at the end of the first quarter of 2022” a positive CHMP recommendation for conditional approval of VLA2001 for primary immunization in adults aged 18 to 55. After that, the company expects the first deliveries to European countries “at the beginning of the second quarter of 2022”.
HOW DOES IT WORK – “We are satisfied with the initial assessment of the CHMP and we look forward to providing our answers as soon as possible”, said the CEO of Valneva, Thomas Lingelbach, recalling that “VLA2001 is the only inactivated Covid-19 vaccine in development. clinician in Europe and this brings us closer to our goal of offering a differentiated option to the population and doctors who need it “.
Unlike those authorized so far by the EMA, the Valneva vaccine contains the inactivated version of the pandemic coronavirus. “Adults aged between 18 and 55 represent the vast majority of unvaccinated people in Europe – highlights the CEO – and we continue to receive messages every day from many who are looking for a more traditional and consolidated vaccination approach”.
The company is also underway “further clinical studies – reads a note – with the aim of gradually expanding the indications of VLA2001 to other age groups”, as well as “for a potential use” of the product “as a booster vaccine in the course of 2022 “.
Valneva signed an agreement with the European Commission in November 2021, to deliver up to 60 million doses of VLA2001 over 2 years, including 24.3 million in 2022.
#Valneva #vaccine #inactivated #virus #Ema #coming